Please login to the form below

Not currently logged in
Email:
Password:

US Biomedical Advanced Research and Development Authority

This page shows the latest US Biomedical Advanced Research and Development Authority news and features for those working in and with pharma, biotech and healthcare.

US pays $1.5bn for 100 million doses of Moderna’s COVID-19 vaccine

US pays $1.5bn for 100 million doses of Moderna’s COVID-19 vaccine

The latest funding follows a previous cash injection from the US Biomedical Advanced Research and Development Authority (BARDA) totalling $955m. ... We are advancing the clinical development of mRNA-1273 with the ongoing phase 3 study being conducted in

Latest news

  • J&J inks $1bn deal with US for coronavirus vaccine J&J inks $1bn deal with US for coronavirus vaccine

    Under the terms of the deal, the US’ Biomedical Advanced Research and Development Authority (BARDA) and the US Department of Defense are committing $1bn for the first 100 million doses. ... We are scaling up production in the US and worldwide to

  • J&J’s COVID-19 vaccine generates positive pre-clinical results J&J’s COVID-19 vaccine generates positive pre-clinical results

    J&J and the US government’s Biomedical Advanced Research and Development Authority ( BARDA) have collectively committed $1bn to the vaccine project, which will be spent on R&D and clinical ... The findings give us confidence as we progress our vaccine

  • Emergent inks $174m deal with AstraZeneca to manufacture COVID-19 vaccine Emergent inks $174m deal with AstraZeneca to manufacture COVID-19 vaccine

    The agreement covers contract development and manufacturing services for AstraZeneca’s adenovirus-based COVID-19 vaccine candidate, AZD1222, which is currently being developed at Oxford University. ... Under that deal, the US Biomedical Advanced

  • J&J says COVID-19 vaccine could be ready in early 2021 J&J says COVID-19 vaccine could be ready in early 2021

    It has also received US federal backing to ramp up manufacturing for the shot, including new capacity in the US and expanded production overseas, with the aim of making a billion ... J&J and the US government’s Biomedical Advanced Research and

  • FDA approves Roche’s Actemra COVID-19 trial FDA approves Roche’s Actemra COVID-19 trial

    Previous research has suggested that elevated IL-6 – a biomarker for inflammation and a high-level immune response – is associated with a higher mortality in people with community-acquired pneumonia. ... Roche had announced its intent to collaborate

More from news
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • Developing a COVID-19 vaccine Developing a COVID-19 vaccine

    The phase 1 study, which is being conducted by the US National Institutes of Health (NIH) at Kaiser Permanente Washington Health Research Institute in Seattle, aims to recruit 45 healthy men ... That includes an agreement with the US Biomedical Advanced

  • Deal Watch June 2016 Deal Watch June 2016

    One of the companies developing pathogen reduction systems for donated blood, Cerus Corporation, signed an agreement in June worth up to $180m with the US Biomedical Advanced Research and Development Authority ... Includes rights to sublicense outside

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics